A small cassette enables conditional gene inactivation by CRISPR/Cas9

被引:0
|
作者
Paloma M. Guzzardo
Christina Rashkova
Rodrigo L. dos Santos
Raha Tehrani
Philippe Collin
Tilmann Bürckstümmer
机构
[1] Horizon Genomics GmbH,
[2] Horizon Discovery Ltd,undefined
来源
Scientific Reports | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The availability of CRISPR/Cas9 technology has enabled the rapid establishment of gene knockouts in many cell types and even whole organisms. However, conditional inactivation of essential genes remains a challenge. We devised an approach named DECAI (DEgradation based on Cre-regulated- Artificial Intron). It utilizes a small cassette of just 201 nucleotides that is inserted into the coding exon of a target gene using CRISPR/Cas9 technology and homology-directed repair. As its sequence is derived from an artificial intron, the cassette is removed by the splicing machinery and thus leaves no trace in the “off-state”. Upon activation with Cre recombinase (“on-state”), the intron is crippled and the target gene is disrupted by a series of stop codons. We exemplify the utility of this approach on several non-essential and essential human genes. Clones bearing the conditional knockout cassette are recovered at frequencies above 5% and cassette function can be traced at the genomic DNA and the mRNA level. Importantly, cassette activation leads to loss of gene expression as judged by flow cytometry, Western blot or immunofluorescence. Altogether, this highlights the broad utility of the approach for conditional gene inactivation and suggests that this tool could be used to study the loss-of-function phenotypes of essential genes.
引用
收藏
相关论文
共 50 条
  • [31] Advances in CRISPR/Cas9
    Zhu, Youmin
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [32] Impact of Target Cell Gender and X-Inactivation on Efficiency of Gene Editing with CRISPR/Cas9
    Baek, Eun Jung
    Yu, Kyung-Rok
    Corat, Marcus A. F.
    Dunbar, Cynthia E.
    MOLECULAR THERAPY, 2017, 25 (05) : 80 - 81
  • [33] Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid
    Sahel, Deepak Kumar
    Goswami, Sangam Giri
    Jatyan, Reena
    Kumari, Anupma
    Mittal, Anupama
    Ramalingam, Sivaprakash
    Chitkara, Deepak
    MACROMOLECULAR RAPID COMMUNICATIONS, 2023, 44 (14)
  • [34] Efficient and Heritable Gene Targeting in Tilapia by CRISPR/Cas9
    Li, Minghui
    Yang, Huihui
    Zhao, Jiue
    Fang, Lingling
    Shi, Hongjuan
    Li, Mengru
    Sun, Yunlv
    Zhang, Xianbo
    Jiang, Dongneng
    Zhou, Linyan
    Wang, Deshou
    GENETICS, 2014, 197 (02) : 591 - U219
  • [35] CRISPR/Cas9 gene editing for genodermatoses: progress and perspectives
    Naso, Gaetano
    Petrova, Anastasia
    EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (03) : 313 - 326
  • [36] CRISPR/CAS9 GENE EDITING TO BLOCK MALARIA TRANSMISSION
    Simoes, Maria
    Dong, Yuemei
    Dimopoulos, George
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 262 - 262
  • [37] CRISPR/Cas9 gene editing therapies for cystic fibrosis
    Graham, Carina
    Hart, Stephen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (06) : 767 - 780
  • [38] User-Friendly Genetic Conditional Knockout Strategies by CRISPR/Cas9
    Chen, Liangliang
    Ye, Ying
    Dai, Hongxia
    Zhang, Heyao
    Zhang, Xue
    Wu, Qiang
    Zhu, Zhexin
    Spalinskas, Rapolas
    Ren, Wenyan
    Zhang, Wensheng
    STEM CELLS INTERNATIONAL, 2018, 2018
  • [39] Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control
    Brown, Wes
    Zhou, Wenyuan
    Deiters, Alexander
    CHEMBIOCHEM, 2021, 22 (01) : 63 - 72
  • [40] Guidelines for optimized gene knockout using CRISPR/Cas9
    Van Campenhout, Claude
    Cabochette, Pauline
    Veillard, Anne-Clemence
    Laczik, Miklos
    Zelisko-Schmidt, Agnieszka
    Sabatel, Celine
    Dhainaut, Maxime
    Vanhollebeke, Benoit
    Gueydan, Cyril
    Kruys, Veronique
    BIOTECHNIQUES, 2019, 66 (06) : 295 - 302